The current research paradigm for Huntington's disease is based on participants with overt
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …

Neurodevelopmental disorders such as intellectual disability, autism spectrum disorder and
schizophrenia lack precise boundaries in their clinical definitions, epidemiology, genetics …

There is growing interest in the biology of dysbindin and its genetic locus (DTNBP1) due to
genetic variants associated with an increased risk of schizophrenia. Reduced levels of …

Huntington's disease (HD) is an autosomal-dominant inherited neurodegenerative disorder
that is caused by expansion of a CAG-repeat tract in the huntingtin gene and characterized …

Failure of oligodendrocyte precursor cells (OPCs) to differentiate and remyelinate axons is
thought to be a major cause of the limited ability of the central nervous system to repair …

Neurodevelopmental disorders arise from single or multiple gene defects. However, the way
multiple loci interact to modify phenotypic outcomes remains poorly understood. Here, we …

Introduction Patient-level data sharing has the potential to significantly impact the lives of
patients by optimizing and improving the medical product development process. In the product …

Post-mortem analysis has revealed reduced levels of the protein dysbindin in the brains of
those suffering from the neurodevelopmental disorder schizophrenia. Consequently, …

Multiple sclerosis (MS) is a chronic, inflammatory demyelinating disease of the CNS. In
addition to motor, sensory and visual deficits, MS is also characterized by hippocampal …

Dysbindin is a schizophrenia susceptibility factor and subunit of the biogenesis of lysosome-related
organelles complex 1 (BLOC-1) required for lysosome-related organelle biogenesis, …